Discovery of anilino-1, 4-naphthoquinones as potent EGFR tyrosine kinase inhibitors: synthesis, biological evaluation, and comprehensive molecular modeling
P Mahalapbutr, R Leechaisit, A Thongnum… - ACS …, 2022 - ACS Publications
Epidermal growth factor receptor (EGFR) has been recognized as one of the attractive
targets for anticancer drug development. Herein, a set of anilino-1, 4-naphthoquinone …
targets for anticancer drug development. Herein, a set of anilino-1, 4-naphthoquinone …
Discovery of Anilino-1, 4-naphthoquinones as Potent EGFR Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Comprehensive Molecular Modeling
P Mahalapbutr, R Leechaisit, A Thongnum… - ACS …, 2022 - pubmed.ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) has been recognized as one of the attractive
targets for anticancer drug development. Herein, a set of anilino-1, 4-naphthoquinone …
targets for anticancer drug development. Herein, a set of anilino-1, 4-naphthoquinone …
Discovery of Anilino-1, 4-naphthoquinones as Potent EGFR Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Comprehensive Molecular Modeling
P Mahalapbutr, R Leechaisit, A Thongnum… - 2022 - ir.swu.ac.th
Epidermal growth factor receptor (EGFR) has been recognized as one of the attractive
targets for anticancer drug development. Herein, a set of anilino-1, 4-naphthoquinone …
targets for anticancer drug development. Herein, a set of anilino-1, 4-naphthoquinone …
Discovery of Anilino-1, 4-naphthoquinones as Potent EGFR Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Comprehensive Molecular Modeling
P Mahalapbutr, R Leechaisit, A Thongnum… - ACS …, 2022 - mahidol.elsevierpure.com
Epidermal growth factor receptor (EGFR) has been recognized as one of the attractive
targets for anticancer drug development. Herein, a set of anilino-1, 4-naphthoquinone …
targets for anticancer drug development. Herein, a set of anilino-1, 4-naphthoquinone …
[HTML][HTML] Discovery of Anilino-1, 4-naphthoquinones as Potent EGFR Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Comprehensive Molecular …
P Mahalapbutr, R Leechaisit, A Thongnum… - ACS Omega, 2022 - ncbi.nlm.nih.gov
Epidermal growth factor receptor (EGFR) has been recognized as one of the attractive
targets for anticancer drug development. Herein, a set of anilino-1, 4-naphthoquinone …
targets for anticancer drug development. Herein, a set of anilino-1, 4-naphthoquinone …
Discovery of Anilino-1, 4-naphthoquinones as Potent EGFR Tyrosine Kinase Inhibitors: Synthesis, Biological Evaluation, and Comprehensive Molecular Modeling.
P Mahalapbutr, R Leechaisit, A Thongnum… - ACS Omega, 2022 - europepmc.org
Epidermal growth factor receptor (EGFR) has been recognized as one of the attractive
targets for anticancer drug development. Herein, a set of anilino-1, 4-naphthoquinone …
targets for anticancer drug development. Herein, a set of anilino-1, 4-naphthoquinone …